Skip to main content
SpringerLink
Log in

Combined positron emission tomography–computed tomography and tumor markers for detecting recurrent ovarian cancer

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

To evaluate the accuracy of integrated FDG-PET/CT and tumor markers for the depiction of recurrent ovarian carcinoma.

Methods

Patients with pathologically proven ovarian cancer, who underwent cytoreductive surgery and 3–6 cycles of adjuvant chemotherapy, were included in this study. They all underwent a thorough physical examination, tumor marker determination, and FDG-PET/CT imaging. The sensitivity, specificity, accuracy, and positive and negative predictive values for the tumor detection with PET/CT versus different tumor markers were performed in relation to the results at histological analysis after second-look surgery or clinical follow-up.

Results

A total of 37 patients underwent FDG-PET/CT scans. Among them, 22 patients underwent exploratory laparotomy and 15 had diagnostic laparoscopy. Overall, 24 patients were documented to have ovarian cancer recurrence after second operation. FDG-PET/CT had sensitivity, specificity, accuracy, and positive and negative predictive values of 100, 85, 94, 92, and 100%, respectively.

Conclusion

Our study has shown that PET/CT is a sensitive tool to assist in the early identification and recurrent ovarian cancer, amenable to secondary cytoreduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cure research.com (2008) Statistics by country for ovarian cancer. http://www.cureresearch.com/o/ovarian_cancer/stats-country.htm. Accessed 9 Apr 2008

  2. Garcia-Veloso MJ, Jurado M, Ceamanos C, Aramendia JM, Garrastachu MP, Lopez-Garcia G, Richer JA (2007) Diagnostic accuracy of FDG PET in the follow-up of platinum sensitive epithelial ovarian carcinoma. Eur J Nuc Med Mol Imaging 34:1396–1405

    Article  Google Scholar 

  3. Gu P, Pan LL, Wu SQ, Sun L, Huang G (2007) CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systemic review and meta-analysis. J Clin Lab Anal 21:398–405

    Article  CAS  PubMed  Google Scholar 

  4. Rustin CJ, Nelstrop AE, Tuxen MK, Lamber HE (1996) Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study. Ann Oncol 7:361–364

    CAS  PubMed  Google Scholar 

  5. Santillan A, Garg R, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK, Bristow RE (2005) Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range. J Clin Oncol 23:9338–9343

    Article  PubMed  Google Scholar 

  6. Engelen ML, de Bruijn HW, Hollwema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG (2000) Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 78:16–20

    Article  CAS  PubMed  Google Scholar 

  7. Motoyama T, Watanabe H, Takeuchi S, Watanabe T, Gotoh S, Okazaki E (1990) Cancer antigen 125, carcinoembryonic antigen and carbohydrate determinant 19-9 in ovarian tumors. Cancer 66:2628–2635

    Google Scholar 

  8. Ak I, Stokkel MPM, Pauwels EJK (2000) Positron emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose in oncology. J Cancer Res Clin Oncol 126:560–574

    Article  CAS  PubMed  Google Scholar 

  9. Nakamoto Y, Saga T, Fujii S (2005) Positron emission tomography application for gynecologic tumors. Int J Gynecol Cancer 15(5):701–709

    Google Scholar 

  10. Cho SM, Ha HK, Byun JY, Lee JM, Kin CJ, Nam-Kong SE, Lee JM (2002) Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. Am J Roentgenol 179(2):391–395

    Google Scholar 

  11. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC (2002) Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85:53–58

    Article  CAS  PubMed  Google Scholar 

  12. Bristow RE, Giuntoli RL, Pannu HK, Schulick RD, Fishman EK, Wahl RL (2005) Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99:294–300

    Article  PubMed  Google Scholar 

  13. Thrall MM, DeLoia JA, Gallion H, Avril N (2007) Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105:17–22

    Article  PubMed  Google Scholar 

  14. National Institutes of Health (1994) Ovarian cancer: screening, treatment and follow-up. NIH Consensus Statement 1994, vol 12, pp 1–30

  15. Meyer T, Rustin GJS (2000) Role of tumor markers in monitoring epithelial ovarian cancer. Br J Cancer 83:1535–1538

    Google Scholar 

  16. Sugiyama T, Nishida T, Komai K et al (1996) Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer. Int J Gynecol Obstet 54:251–256

    Article  CAS  Google Scholar 

  17. Ferazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA et al (1997) Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring system in multicenter study. Ultrasound Obstet Gynecol 10:192–197

    Article  Google Scholar 

  18. Forstner R, Hricak H, Powell CB et al (1995) Ovarian cancer recurrence: value of MR imaging. Radiology 196:715–720

    CAS  PubMed  Google Scholar 

  19. Kim CK, Park BK, Choi JY, Kim BG, Han H (2007) Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr 31:868–875

    Article  PubMed  Google Scholar 

  20. De Rosa V, Mangoni de Stefano ML, Brunetti A et al (1995) Computer tomography and second look surgery in ovarian cancer patient: correlation, actual role and limitations of CT scan. Eur J Gynecol Concol 16:123–129

    Google Scholar 

  21. Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL, Montz FJ (2003) Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 20:519–528

    Article  Google Scholar 

  22. Jimenez-Bonilla J, Maldonado A, Morales S, Salud A, Zomeno M, Roman J, Bolen J, Moya F (2000) Clinical impact of 18F-FDG-PET in the suspicion of recurrent ovarian carcinoma based on elevated tumor marker serum levels. Clin Positron Imaging 3:231–236

    Article  PubMed  Google Scholar 

  23. Murakami M, Miyamoto T, Iida T, Tsukada M, Watanabe M, Shida M, Maeda H, Nasu S, Yasuda S, Yasuda M, Ide M (2006) Whole body positron emission tomography and tumor marker CA 125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):99–107

    Article  PubMed  Google Scholar 

  24. Takekuma M, Maeda M, Ozawa T, Yasumi K, Torizuka T (2005) Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. Int J Clin Oncol 10:17–81

    Article  Google Scholar 

  25. Rubin SC, Hoskins WJ, Hakes TB, Markman M, Reichman BS, Chapman D, Lewis JL (1989) Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 160:667–671

    CAS  PubMed  Google Scholar 

  26. Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP (2007) Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med mol Imaging 34:480–486

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Shin-Kong Wu-Ho-Su Memorial Hospital, No 95, Wen-Chang Road, Shih-Lin District, Taipei, Taiwan

    Hun-Shan Pan, Shiow-Lin Lee & Lee-Wen Huang

  2. Medical College, Fu-Jen Catholic University, Taipei, Taiwan

    Hun-Shan Pan & Lee-Wen Huang

  3. College of Public Health, National Yang-Ming University, Taipei, Taiwan

    Hun-Shan Pan

  4. Department of Radiology, Shin-Kong Wu-Ho-Su Memorial Hospital, Taipei, Taiwan

    Yen-Kung Chen

Authors
  1. Hun-Shan Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiow-Lin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lee-Wen Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yen-Kung Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shiow-Lin Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, HS., Lee, SL., Huang, LW. et al. Combined positron emission tomography–computed tomography and tumor markers for detecting recurrent ovarian cancer. Arch Gynecol Obstet 283, 335–341 (2011). https://doi.org/10.1007/s00404-010-1404-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1404-6

Keywords

Search

Navigation